BEVERLY, Mass., July 9, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced preliminary financial results for the second quarter of 2024. The Company now expects revenue to be greater than $252 million, and diluted earnings per share to be greater than $1.38, compared to the Company's previously issued revenue guidance of $245 million and diluted earnings per share of $1.30. In addition, the Company continues to expect second half performance to be stronger than the first half, slightly weighted towards the fourth quarter. These preliminary financial results are management's estimates and are subject to revision in the course of completing quarterly review processes. Final results for the quarter will be publicly reported by the Company on July 31, 2024, prior to a Form 10-Q filing for the quarter with full financial statements. President and CEO Russell Low commented, "We delivered a solid quarter as chipmakers across the globe continue to rely on Axcelis' Purion platform to support their operations. Systems revenue was better than we anticipated, partly due to better conversion of evaluation systems to revenue. The fundamentals supporting Axcelis' growth remain strong, and we look forward to discussing our market opportunities, growth strategy and long-term ...